生物製藥市場規模、佔有率、成長分析（按類型、分銷管道、應用和地區）—2025 年至 2032 年產業預測

預計生物製藥市場規模將在 2023 年達到 5,703 億美元，從 2024 年的 6,085.1 億美元成長到 2032 年的 1,2,231 億美元，預測期內（2025-2032 年）的複合年成長率為 6.7%。

根據市場洞察，由於全球人口成長以及與老齡化相關的疾病和慢性疾病的增加，對生物製藥的需求正在成長。世界衛生組織 (WHO) 預測，到 2020 年，65 歲及以上成年人的數量將超過 5 歲以下兒童的數量，到 2050 年這一趨勢也將保持不變。這種人口結構變化增加了對醫療保健服務的需求，以管理癌症、神經系統疾病和心血管疾病等老年人中普遍存在的疾病。家庭和專業護理需求的不斷成長進一步擴大了這種需求，並鼓勵生物製藥公司在研發方面投入更多資金。此外，生物製藥監管部門的核准不斷增加，有望加快創新治療方法的獲取，這將在未來幾年顯著推動市場成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

生物製藥市場規模（按類型及複合年成長率） (2025-2032)

• 市場概覽
• 免疫調節藥物
  • 單株抗體
  • 細胞激素
  • 干擾素
  • 其他
• 酵素
  • 水解酶
  • 解離酶
  • 氧化還原酶
  • 其他
• 疫苗
  • 重組/複合物/次單元
  • 惰性
  • 減毒活疫苗
  • 類毒素
• 荷爾蒙
  • 人體生長荷爾蒙
  • 胰島素
  • 甲狀腺刺激素
  • 其他
• 其他

生物製藥市場規模（依通路分類）及複合年成長率（2025-2032）

• 市場概覽
• 醫院藥房
• 藥局和藥房
• 網路藥局

生物製藥市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概覽
• 心臟病學
• 腫瘤學
• 呼吸系統
• 免疫學
• 神經病學
• 其他

生物製藥市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Lonza Group（Switzerland）
• WuXi Biologics（China）
• Fujifilm Diosynth Biotechnologies（Japan）
• Recipharm（Sweden）
• Samsung Biologics（South Korea）
• Boehringer Ingelheim（Germany）
• Catalent（USA）
• Thermo Fisher Scientific（USA）
• Siegfried Holding AG（Switzerland）
• AGC Biologics（Japan）
• WuXi AppTec（China）
• Cambrex Corporation（USA）
• Charles River Laboratories（USA）
• Chugai Pharmaceutical（Japan）
• Biocon Limited（India）
• Dr. Reddy's Laboratories（India）
• Sun Pharmaceutical Industries（India）
• Teva Pharmaceutical Industries（Israel）
• Novartis（Switzerland）

結論和建議

Biopharmaceuticals Market size was valued at USD 570.3 billion in 2023 and is poised to grow from USD 608.51 billion in 2024 to USD 1022.31 billion by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

Market insights reveal a growing demand for biopharmaceuticals, driven by an increasing global population coupled with a rise in age-related diseases and chronic medical conditions. The World Health Organization notes that in 2020, adults aged 65 and older outnumbered children under five, a trend expected to equalize by 2050. This demographic shift is prompting heightened demand for healthcare services, particularly to manage disorders like cancer, neurological conditions, and cardiovascular diseases prevalent among seniors. The rising need for both family and professional care further amplifies this demand, encouraging biopharmaceutical companies to boost investments in research and development. Additionally, an uptick in regulatory approvals for biopharmaceutical products promises expedited access to innovative treatments, significantly propelling the market's growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biopharmaceuticals market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biopharmaceuticals Market Segments Analysis

Global Biopharmaceuticals Market is segmented by Type, Distribution Channel, Application and region. Based on Type, the market is segmented into Immunomodulators, Enzymes, Vaccines, Hormones and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Pharmacies. Based on Application, the market is segmented into Cardiology, Oncology, Respiratory, Immunology, Neurology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biopharmaceuticals Market

A significant driver fueling the growth of the biopharmaceuticals market is the escalating prevalence of chronic diseases worldwide. This alarming rise has prompted governments across various regions to initiate awareness campaigns aimed at educating the public about these conditions, resulting in a heightened focus on treatment options. Consequently, the demand for medications in the biopharmaceutical sector, particularly those targeting specialized areas such as rare, chronic, and hereditary disorders, is expected to see a steady increase. As more individuals become aware of their healthcare options, the market is poised for substantial expansion, driven by the need for effective therapeutic solutions.

Restraints in the Biopharmaceuticals Market

The biopharmaceuticals market faces significant restraints due to the elevated costs associated with development and production. The complex manufacturing processes and stringent regulatory requirements necessitate advanced technologies, resulting in the higher overall expense of biologics. This inflated cost can create barriers to access and limit affordability for numerous patients and healthcare systems. Consequently, the financial challenges linked to the development and formulation of biopharmaceuticals mean that many individuals may not benefit from these innovative therapies, ultimately hindering the market's growth and restricting patient access to essential treatments.

Market Trends of the Biopharmaceuticals Market

The biopharmaceutical market is witnessing a transformative trend in gene and cell therapies, which address pressing healthcare needs, particularly for rare diseases, cancers, and genetic disorders. These innovative therapies are ushering in a new era of personalized medicine, offering potential curative solutions through targeted cell or DNA replacement. The efficacy of these treatments is bolstered by breakthroughs in viral vector delivery systems and CRISPR technology, enhancing precision and outcomes. However, challenges related to high costs and navigating regulatory approvals remain prominent. As research and development efforts continue, the market is anticipated to expand significantly, revolutionizing patient care and treatment paradigms.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Biopharmaceuticals Market Size by Type & CAGR (2025-2032)

• Market Overview
• Immunomodulators
  • Monoclonal Antibodies
  • Cytokines
  • Interferons
  • Others
• Enzymes
  • Hyrdolases
  • Lyases
  • Oxidoreductases
  • Others
• Vaccines
  • Recombinant/Conjugate/Subunit
  • Inactivated
  • Live Attenuated
  • Toxoid
• Hormones
  • Human Growth Hormones
  • Insulin
  • Thyroid Stimulating Hormones
  • Others
• Others

Global Biopharmaceuticals Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies

Global Biopharmaceuticals Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiology
• Oncology
• Respiratory
• Immunology
• Neurology
• Others

Global Biopharmaceuticals Market Size & CAGR (2025-2032)

• North America (Type, Distribution Channel, Application)
  • US
  • Canada
• Europe (Type, Distribution Channel, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Distribution Channel, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Distribution Channel, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Distribution Channel, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi Biologics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Diosynth Biotechnologies (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recipharm (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siegfried Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AGC Biologics (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chugai Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations